These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15842656)

  • 1. Somatic PTPN11 mutations in childhood acute myeloid leukaemia.
    Tartaglia M; Martinelli S; Iavarone I; Cazzaniga G; Spinelli M; Giarin E; Petrangeli V; Carta C; Masetti R; Aricò M; Locatelli F; Basso G; Sorcini M; Pession A; Biondi A
    Br J Haematol; 2005 May; 129(3):333-9. PubMed ID: 15842656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer Group.
    Loh ML; Reynolds MG; Vattikuti S; Gerbing RB; Alonzo TA; Carlson E; Cheng JW; Lee CM; Lange BJ; Meshinchi S;
    Leukemia; 2004 Nov; 18(11):1831-4. PubMed ID: 15385933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia.
    Tartaglia M; Martinelli S; Cazzaniga G; Cordeddu V; Iavarone I; Spinelli M; Palmi C; Carta C; Pession A; Aricò M; Masera G; Basso G; Sorcini M; Gelb BD; Biondi A
    Blood; 2004 Jul; 104(2):307-13. PubMed ID: 14982869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the prevalence of PTPN11 mutations in FAB M5 paediatric acute myeloid leukaemia.
    Goemans BF; Zwaan CM; Martinelli S; Harrell P; de Lange D; Carta C; Reinhardt D; Hählen K; Creutzig U; Tartaglia M; Heinrich MC; Kaspers GJ
    Br J Haematol; 2005 Sep; 130(5):801-3. PubMed ID: 16115145
    [No Abstract]   [Full Text] [Related]  

  • 5. Mutations of FLT3, NRAS, KRAS, and PTPN11 are frequent and possibly mutually exclusive in high hyperdiploid childhood acute lymphoblastic leukemia.
    Paulsson K; Horvat A; Strömbeck B; Nilsson F; Heldrup J; Behrendtz M; Forestier E; Andersson A; Fioretos T; Johansson B
    Genes Chromosomes Cancer; 2008 Jan; 47(1):26-33. PubMed ID: 17910045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTPN11, RAS and FLT3 mutations in childhood acute lymphoblastic leukemia.
    Yamamoto T; Isomura M; Xu Y; Liang J; Yagasaki H; Kamachi Y; Kudo K; Kiyoi H; Naoe T; Kojma S
    Leuk Res; 2006 Sep; 30(9):1085-9. PubMed ID: 16533526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.
    Kiyoi H; Naoe T; Nakano Y; Yokota S; Minami S; Miyawaki S; Asou N; Kuriyama K; Jinnai I; Shimazaki C; Akiyama H; Saito K; Oh H; Motoji T; Omoto E; Saito H; Ohno R; Ueda R
    Blood; 1999 May; 93(9):3074-80. PubMed ID: 10216104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis.
    Loh ML; Vattikuti S; Schubbert S; Reynolds MG; Carlson E; Lieuw KH; Cheng JW; Lee CM; Stokoe D; Bonifas JM; Curtiss NP; Gotlib J; Meshinchi S; Le Beau MM; Emanuel PD; Shannon KM
    Blood; 2004 Mar; 103(6):2325-31. PubMed ID: 14644997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of internal tandem duplications and activating point mutations in FLT3 in acute myeloid leukemia in elderly patients.
    Andersson A; Johansson B; Lassen C; Mitelman F; Billström R; Fioretos T
    Eur J Haematol; 2004 May; 72(5):307-13. PubMed ID: 15059064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAS, FLT3, and TP53 mutations in therapy-related myeloid malignancies with abnormalities of chromosomes 5 and 7.
    Side LE; Curtiss NP; Teel K; Kratz C; Wang PW; Larson RA; Le Beau MM; Shannon KM
    Genes Chromosomes Cancer; 2004 Mar; 39(3):217-23. PubMed ID: 14732923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia.
    Goemans BF; Zwaan CM; Miller M; Zimmermann M; Harlow A; Meshinchi S; Loonen AH; Hählen K; Reinhardt D; Creutzig U; Kaspers GJ; Heinrich MC
    Leukemia; 2005 Sep; 19(9):1536-42. PubMed ID: 16015387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.
    Bentires-Alj M; Paez JG; David FS; Keilhack H; Halmos B; Naoki K; Maris JM; Richardson A; Bardelli A; Sugarbaker DJ; Richards WG; Du J; Girard L; Minna JD; Loh ML; Fisher DE; Velculescu VE; Vogelstein B; Meyerson M; Sellers WR; Neel BG
    Cancer Res; 2004 Dec; 64(24):8816-20. PubMed ID: 15604238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of the PTPN11 and RAS genes in rhabdomyosarcoma and pediatric hematological malignancies.
    Chen Y; Takita J; Hiwatari M; Igarashi T; Hanada R; Kikuchi A; Hongo T; Taki T; Ogasawara M; Shimada A; Hayashi Y
    Genes Chromosomes Cancer; 2006 Jun; 45(6):583-91. PubMed ID: 16518851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia.
    Case M; Matheson E; Minto L; Hassan R; Harrison CJ; Bown N; Bailey S; Vormoor J; Hall AG; Irving JA
    Cancer Res; 2008 Aug; 68(16):6803-9. PubMed ID: 18701506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in PTPN11 are uncommon in adult myelodysplastic syndromes and acute myeloid leukaemia.
    Johan MF; Bowen DT; Frew ME; Goodeve AC; Wilson GA; Peake IR; Reilly JT
    Br J Haematol; 2004 Mar; 124(6):843-4. PubMed ID: 15009076
    [No Abstract]   [Full Text] [Related]  

  • 16. FLT3 mutations are associated with other molecular lesions in AML.
    Carnicer MJ; Nomdedéu JF; Lasa A; Estivill C; Brunet S; Aventín A; Sierra J
    Leuk Res; 2004 Jan; 28(1):19-23. PubMed ID: 14630076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of PTPN11 are rare in adult myeloid malignancies.
    Hugues L; Cavé H; Philippe N; Pereira S; Fenaux P; Preudhomme C
    Haematologica; 2005 Jun; 90(6):853-4. PubMed ID: 15951301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a human acute myeloid leukaemia screening panel and consequent identification of novel gene mutation in FLT3 and CCND3.
    Smith ML; Arch R; Smith LL; Bainton N; Neat M; Taylor C; Bonnet D; Cavenagh JD; Andrew Lister T; Fitzgibbon J
    Br J Haematol; 2005 Feb; 128(3):318-23. PubMed ID: 15667533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemia.
    Niihori T; Aoki Y; Ohashi H; Kurosawa K; Kondoh T; Ishikiriyama S; Kawame H; Kamasaki H; Yamanaka T; Takada F; Nishio K; Sakurai M; Tamai H; Nagashima T; Suzuki Y; Kure S; Fujii K; Imaizumi M; Matsubara Y
    J Hum Genet; 2005; 50(4):192-202. PubMed ID: 15834506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FLT3/ITD mutation signaling includes suppression of SHP-1.
    Chen P; Levis M; Brown P; Kim KT; Allebach J; Small D
    J Biol Chem; 2005 Feb; 280(7):5361-9. PubMed ID: 15574429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.